{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-22-000033","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2022-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.120781+00:00","generated_at":"2026-06-26T13:48:51.188389+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Immunovant R&D Day presentation filed; details not fully available in text","bullets":["Immunovant hosted a virtual R&D Day on March 30, 2022; presentation filed as Exhibit 99.1.","The filed exhibit contains only the title slide; no specific data or updates are extractable from the provided text.","Investors should refer to the complete presentation for pipeline and clinical trial updates."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-22-000033","json":"https://secwatch.observer/filing/0001764013-22-000033.json","markdown":"https://secwatch.observer/filing/0001764013-22-000033.md","text":"https://secwatch.observer/filing/0001764013-22-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000033/0001764013-22-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000033/imvt-20220330.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T13:48:51.188389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}